Nautilus Biotechnolgy, Inc. Common Stock Share Price
NASDAQ: NAUTHealthcare
Live Nautilus Biotechnolgy, Inc. Common Stock Share Price Chart
O H L
Nautilus Biotechnolgy, Inc. Common Stock Performance Overview
Days Range
▼
$0.94Low
$0.96High
Markets Today
| Previous Close | $0.97 |
|---|---|
| Open | $0.96 |
| Volume | 121,991 |
| Day's Range | $0.94 - $0.96 |
| 52W Range | $0.68 - $4.31 |
| Market Cap | $123.70 M |
Historical Performance
| 1M Returns | +14.08 |
|---|---|
| 3M Returns | -57.38 |
| 6M Returns | -64.54 |
| 1Y Returns | +33.31 |
| 5Y Returns | -85.63 |
| 10Y Returns | NA |
Nautilus Biotechnolgy, Inc. Common Stock Fundamentals
| Market Cap | $123.70 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.32 |
| EPS TTM | $-0.45 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.94 |
| EBITDA | $-65.08 M |
| Profit Margin | N/A |
| Market Cap | $123.70 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.32 |
| EPS TTM | $-0.45 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.94 |
| EBITDA | $-65.08 M |
| Profit Margin | N/A |
Nautilus Biotechnolgy, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $190.00 K |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $175.00 K |
| Operating Income | -$18.84 M | -$17.10 M | -$15.47 M | -$15.42 M | -$16.12 M | -$15.76 M |
| EBITDA | -$18.38 M | -$16.64 M | -$15.05 M | -$15.02 M | -$15.79 M | -$15.49 M |
| Interest Expense | $2.23 M | $2.08 M | $0 | $0 | $1.44 M | $1.31 M |
| Depreciation | $465.00 K | $457.00 K | $426.00 K | $405.00 K | $334.00 K | $272.00 K |
| Income Before Tax | -$16.61 M | -$15.03 M | -$13.57 M | -$13.78 M | -$14.70 M | -$14.47 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$16.61 M | -$15.03 M | -$13.57 M | -$13.78 M | -$14.70 M | -$14.47 M |
| Net Profit Margin | - | - | - | - | - | -7615.26% |
Nautilus Biotechnolgy, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $13.00 K | $13.00 K | $13.00 K | $13.00 K | $13.00 K | $13.00 K |
| Reserve & Surplus | -$289.44 M | -$304.59 M | -$318.04 M | -$331.78 M | -$346.81 M | -$361.52 M |
| Non-Current Liabilities | $25.10 M | $23.96 M | $22.79 M | $26.19 M | $25.02 M | $23.82 M |
| Current Liabilities | $8.16 M | $8.14 M | $8.98 M | $7.95 M | $8.34 M | $8.64 M |
| Total Liabilities | $33.26 M | $32.09 M | $31.78 M | $34.14 M | $33.36 M | $32.46 M |
| Fixed Assets | $3.79 M | $3.73 M | $3.62 M | $3.46 M | $3.63 M | $4.00 M |
| Current Assets | $141.60 M | $150.72 M | $134.32 M | $105.96 M | $98.83 M | $87.63 M |
| Total Assets | $227.69 M | $213.19 M | $200.91 M | $191.11 M | $177.78 M | $163.58 M |
Nautilus Biotechnolgy, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$16.61 M | -$15.03 M | -$13.57 M | -$13.78 M | -$14.70 M | -$14.47 M |
| Operating Cash Flow | -$13.94 M | -$13.35 M | -$11.03 M | -$12.38 M | -$13.10 M | -$13.73 M |
| Investing Cash Flow | $19.51 M | $14.47 M | $452.00 K | $787.00 K | $14.23 M | $12.02 M |
| Financing Cash Flow | $18.00 K | $95.00 K | $0 | $101.00 K | $1.10 M | $244.00 K |
| Change in Cash | $5.59 M | $1.22 M | -$10.58 M | -$11.49 M | $2.24 M | -$1.46 M |
Nautilus Biotechnolgy, Inc. Common Stock Return Calculator
The Nautilus Biotechnolgy, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,405
Invested Amount$10,000
Est. Returns$-8,595
About Nautilus Biotechnolgy, Inc. Common Stock
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Popular Stocks
FAQs
What is the share price of Nautilus Biotechnolgy, Inc. Common Stock today?
Nautilus Biotechnolgy, Inc. Common Stock (NAUT) share price as of September 18, 2026 is $0.95. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Nautilus Biotechnolgy, Inc. Common Stock?
Yes, Indian Investors can invest in the Nautilus Biotechnolgy, Inc. Common Stock (NAUT) Share by opening an international trading account with Angel One.
How can I purchase Nautilus Biotechnolgy, Inc. Common Stock shares in India?
Purchasing Nautilus Biotechnolgy, Inc. Common Stock (NAUT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Nautilus Biotechnolgy, Inc. Common Stock (NAUT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Nautilus Biotechnolgy, Inc. Common Stock?
Yes, you can purchase fractional shares of Nautilus Biotechnolgy, Inc. Common Stock (NAUT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Nautilus Biotechnolgy, Inc. Common Stock?
The market capitalization of Nautilus Biotechnolgy, Inc. Common Stock on September 18, 2026, is $123.70 M.
In which sector Nautilus Biotechnolgy, Inc. Common Stock belongs?
Nautilus Biotechnolgy, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Nautilus Biotechnolgy, Inc. Common Stock stocks?
In order to invest in Nautilus Biotechnolgy, Inc. Common Stock (NAUT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
